AU2013381856A1 — A seamless tubular extracellular matrix prosthetic valve and method for forming same
Assigned to Cormatrix Cardiovascular Inc · Expires 2015-07-16 · 11y expired
What this patent protects
A seamless prosthetic valve comprising a continuous tubular member having an outer abluminal surface, a triple walled intermediate portion, and at least a first valve leaflet that is configured to selectively restrict fluid flow through the valve, the triple walled intermediate p…
USPTO Abstract
A seamless prosthetic valve comprising a continuous tubular member having an outer abluminal surface, a triple walled intermediate portion, and at least a first valve leaflet that is configured to selectively restrict fluid flow through the valve, the triple walled intermediate portion being formed by everting a first end of member over the member, whereby a double walled end is formed, and reverting the first end over the double walled end of the member, the first valve leaflet being formed by suturing the triple walled intermediate portion at a first commissure connection point.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.